EUVIMEDEUVIMED entdecken
Vergleichsstudie

Assessment of Chemotherapy Response in Colorectal Cancer Using PET‐CT Versus DWI‐MRI

Jawad Ali Memon iD, Zubair Ali Memon iD, Mohammad Sibtain Shah iD, Uzma Malik iD, Mohammad Saleh Chandio iD

Journal of Medical Imaging and Radiation Oncology · 2026-04 · 70 (3) · 272-282

DOI: 10.1111/1754-9485.70079 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 05.03.2026. Verfasst von Jawad Ali Memon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Peoples University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan. Hauptthemen laut MEDLINE: Diffusion Magnetic Resonance Imaging, Positron Emission Tomography Computed Tomography, Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluating therapeutic efficacy in colorectal malignancies presents significant challenges when relying solely on conventional anatomical imaging approaches. The primary aim of this prospective study was to compare the diagnostic effectiveness of integrated positron emission tomography–computed tomography (PET‐CT) and diffusion‐weighted magnetic resonance imaging (DWI‐MRI) for monitoring chemotherapy response in patients with colorectal cancer.

Methods

This prospective comparative analysis included 132 histologically confirmed patients with colorectal cancer planned for first‐line chemotherapy (FOLFOX, FOLFIRI, or CAPOX). Twelve of 132 patients left the study during follow‐up. Patients underwent baseline PET‐CT and DWI‐MRI exams, with repeat scans at 3, 6, and 12 weeks post‐treatment. Response assessment used RECIST v1.1 for morphology, PERCIST v1.0 for metabolism, and quantitative apparent diffusion coefficient (ADC) analysis for DWI‐MRI. Survival outcomes, correlation studies, and receiver operating characteristic curve analysis were used.

Results

Patients had a mean age of 62.7 ± 9.6 years, with 51.7% men. PET‐CT indicated a 36.0% ± 25.3% SUVmax reduction, and DWI‐MRI showed a 51.4% ± 42.1% ADC rise at 12 weeks ( p < 0.001). A significant negative association ( r = −0.732, p < 0.001) occurred between SUVmax and ADC values. DWI‐MRI outperformed PET‐CT in terms of diagnostic performance, with an AUC of 0.887 ( p = 0.156), a sensitivity of 90.9% compared to 84.4%, and a specificity of 76.7% compared to 72.1%. Concordant responders demonstrated better progression‐free survival (18.0 vs. 4.8 months, p < 0.001) and overall survival.

Conclusion

Both PET‐CT and DWI‐MRI demonstrate excellent diagnostic performance for assessing chemotherapy response, with DWI‐MRI showing marginal superiority in sensitivity and predictive accuracy, supporting its use as a radiation‐free alternative for treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diffusion Magnetic Resonance ImagingPositron Emission Tomography Computed TomographyColorectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleProspective StudiesFemaleMiddle AgedTreatment OutcomeAgedSensitivity and Specificity

Stichwörter der Autor:innen

chemotherapycolorectal cancerdiagnostic performancediffusion‐weighted MRIpositron emission tomography–computed tomography

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, Peoples University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan.
  • Department of Oncology, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia.
  • Department of Oncology, Peoples University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan.
  • Kuwait Cancer Control Center, Kuwait City, Kuwait.
  • Department of Oncology, Gambat Institute of Medical Sciences (GIMS), Gambat, Sindh, Pakistan.

ORCID-Profile: Jawad Ali Memon, Zubair Ali Memon, Mohammad Sibtain Shah, Uzma Malik, Mohammad Saleh Chandio

Zitieren

APA

Memon, J. A., Memon, Z. A., Shah, M. S., Malik, U., & Chandio, M. S. (2026). Assessment of Chemotherapy Response in Colorectal Cancer Using PET‐CT Versus DWI‐MRI. Journal of Medical Imaging and Radiation Oncology, 70(3), 272-282. https://doi.org/10.1111/1754-9485.70079

Vancouver

Memon JA, Memon ZA, Shah MS, Malik U, Chandio MS. Assessment of Chemotherapy Response in Colorectal Cancer Using PET‐CT Versus DWI‐MRI. Journal of Medical Imaging and Radiation Oncology. 2026;70(3):272-282. doi:10.1111/1754-9485.70079

BibTeX
@article{Memon2026,
  author = {Memon, Jawad Ali and Memon, Zubair Ali and Shah, Mohammad Sibtain and Malik, Uzma and Chandio, Mohammad Saleh},
  title = {Assessment of Chemotherapy Response in Colorectal Cancer Using PET‐CT Versus DWI‐MRI},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2026},
  volume = {70},
  number = {3},
  pages = {272--282},
  doi = {10.1111/1754-9485.70079}
}
Kostenlos starten →